AIG
CRVS icon

American International Group’s Corvus Pharmaceuticals CRVS Stock Holding History

American International Group’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,843
Closed -$36K – 3115
2019
Q1 		$36K Sell
8,843
-287
-3% -$1.21K ﹤0.01% 2940
2018
Q4 		$34K Sell
9,130
-70
-0.8% -$477 ﹤0.01% 2961
2018
Q3 		$79K Buy
9,200
+166
+2% +$1.66K ﹤0.01% 2938
2018
Q2 		$99K Buy
9,034
+3,647
+68% +$40.7K ﹤0.01% 2789
2018
Q1 		$62K Sell
5,387
-289
-5% -$2.73K ﹤0.01% 2845
2017
Q4 		$59K Buy
5,676
+28
+0.5% +$359 ﹤0.01% 2913
2017
Q3 		$90K Buy
5,648
+422
+8% +$5.84K ﹤0.01% 2699
2017
Q2 		$63K Buy
5,226
+3,176
+155% +$33.9K ﹤0.01% 2936
2017
Q1 		$43K Buy
2,050
+140
+7% +$2.19K ﹤0.01% 2867
2016
Q4 		$27K Sell
1,910
-5
-0.3% -$76 ﹤0.01% 2947
2016
Q3 		$31.5K Buy
1,915
+2
+0.1% +$29 ﹤0.01% 2969
2016
Q2 		$27.3K Buy
+1,913
New +$25.8K ﹤0.01% 3036

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
Cowen Inc New York $1.35B AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return